The Journal of Contemporary Dental Practice

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Related articles

VOLUME 21 , ISSUE 2 ( February, 2020 ) > List of Articles

ORIGINAL RESEARCH

Estimation of TNF-α Levels in Saliva and Serum of Patients with Periodontal Health and Chronic Periodontitis: A Case-control Study

Kadhiresan Rathinasamy, Arunmozhi Ulaganathan, Shanmugapriya Ramamurthy, Rathinavelu Ganesan, Parthiban Saket, Swarna Alamelu

Keywords : Chronic periodontitis, Cytokines, Periodontal pockets, Saliva, Serum, Tumor necrosis factor-α

Citation Information : Rathinasamy K, Ulaganathan A, Ramamurthy S, Ganesan R, Saket P, Alamelu S. Estimation of TNF-α Levels in Saliva and Serum of Patients with Periodontal Health and Chronic Periodontitis: A Case-control Study. J Contemp Dent Pract 2020; 21 (2):148-151.

DOI: 10.5005/jp-journals-10024-2765

License: CC BY-NC 4.0

Published Online: 01-02-2020

Copyright Statement:  Copyright © 2020; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Aim: The aim of this case–control study is to estimate the circulatory levels of tumor necrosis factor alpha (TNF-α) in saliva and serum of patients with chronic periodontitis and periodontally healthy subjects. Materials and methods: Forty-four patients were screened, and based on biofilm-gingival interface (BGI) index, they were grouped into group I healthy periodontium [BGI-H (20)] and group II periodontitis [BGI-P3 (24)]. Venous blood and salivary samples were collected and analyzed using solid-phase enzyme-linked immunosorbent assay. Independent sample t test was performed to determine the association. Results: Overall, there were differences in both the saliva and the serum TNF-α levels in healthy and periodontitis subjects. The average serum TNF-α concentration in group I healthy subjects was 23.12 pg/mL and in group II periodontitis was 24.06 pg/mL. In the saliva, the mean TNF-α level in group I healthy subjects was 45.69 pg/mL and in group II diseased subjects was 46.58 pg/mL. However, the values were not statistically significant (p > 0.05). Conclusion: Circulatory and salivary TNF-α levels were found in detectable quantities. They showed a marginal increase in chronic periodontitis patients when compared with normal healthy patients in the absence of systemic diseases. Further studies are required in a large scale and with different methodologies to substantiate the role of TNF-α in the progression of periodontal diseases. Clinical significance: Clinical significance of this study is to analyze the TNF-α levels in saliva and serum, which may be the aggravating factor in causing periodontal disease, thereby helping to treat periodontitis.


PDF Share
  1. Honda T, Domon H, Okui T, et al. Balance of inflammatory response in stable gingivitis and progressive periodontitis lesions. Clin Exp Immunol 2006;144(1):35–40. DOI: 10.1111/j.1365-2249.2006.03028.x.
  2. Hosokawa Y, Hosokawa I, Ozaki K, et al. Increase of CCL 20 expression by human gingival fibroblasts upon stimulation with cytokines and bacterial endotoxin. Clin Exp Immunol 2005;142(2):285–291. DOI: 10.1111/j.1365-2249.2005.02912.x.
  3. Roberts EA, McCaffery KA, Michalek SM. Profile of cytokine mRNA expression in chronic adult periodontitis. J Dent Res 1997;76(12): 1833–1833. DOI: 10.1177/00220345970760120501.
  4. Offenbacher S, Barros SP, Singer RE, et al. Periodontal disease at the biofilm-gingival interface. J Periodontol 2007;78(10):1911–1925. DOI: 10.1902/jop.2007.060465.
  5. Navazesh M. Methods for collecting saliva. Ann N Y Acad Sci 1993;694:72–77. DOI: 10.1111/j.1749-6632.1993.tb18343.x.
  6. Novak K, Novak F. Chronic periodontitis. In: Newman M, Takei H, Klokkevold R, ed. Carranza's Clinical Periodontology, 9th ed., Philadelphia: Saunders; 2006. p. 496.
  7. Kjeldsen M, Holmstrup P, Bendtzen K. Marginal periodontitis and cytokines: a review of the literature. J Periodontol 1993;64(11): 1013–1022. DOI: 10.1902/jop.1993.64.11.1013.
  8. Zambon JJ. Periodontal diseases: microbial factors. Ann Periodontol 1996;1(1):879–925. DOI: 10.1902/annals.1996.1.1.879.
  9. Socransky SS, Haffajee AD, Cugini MA, et al. Microbial complexes in subgingival plaque. J Clin Periodontol 1998;25(2):134–144. DOI: 10.1111/j.1600-051X.1998.tb02419.x.
  10. Ng PY, Donley M, Hausmann E, et al. Candidate salivary biomarkers associated with alveolar bone loss: cross-sectional and in vitro studies. FEMS Immunol Med Microbiol 2007;49(2):252–260. DOI: 10.1111/j.1574-695X.2006.00187.x.
  11. Geng W, Ying-Hui T, Sheng-Gen S. Expression of IL-6 and TNF-α activities in saliva of chronic periodontitis patients. Chin J Conserve Dent 2009;5:11.
  12. Gursoy UK, Könönen E, Uitto VJ, et al. Salivary interleukin-1beta concentration and the presence of multiple pathogens in periodontitis. J Clin Periodontol 2009;36(11):922–927. DOI: 10.1111/j.1600-051X.2009.01480.x.
  13. Rai B. Salivary levels of tumor necrosis factor alpha in periodontitis. Adv Med Dent Sci 2008;2:40–41.
  14. Teles RP, Likhari V, Socransky SS, et al. Salivary cytokine levels in subjects with chronic periodontitis and in periodontally healthy individuals: a cross-sectional study. J Periodontal Res 2009;44(3): 411–417. DOI: 10.1111/j.1600-0765.2008.01119.x.
  15. Slotwinska SM, Slotwinski R. Saliva levels of interleukin-1 receptor antagonist and soluble receptor type I of tumor necrosis factor in chronic periodontitis. Dent Med Probl 2006;43:15–19.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.